Astera Labs (NASDAQ:ALAB) Price Target Cut to $258.00 by Analysts at Susquehanna

Astera Labs (NASDAQ:ALAB) had its target price lowered by analysts at Susquehanna from $310.00 to $258.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Susquehanna‘s price target would suggest a potential upside of 10.44% from the stock’s current price.

Other research analysts have also issued reports about the company. Jefferies Financial Group lifted their target price on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Friday, October 9th. Roth Capital restated a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Weiss Ratings lowered shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research report on Friday, October 23rd. Finally, Zacks Research cut shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Twelve research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $331.47.

Astera Labs Stock Performance

Shares of ALAB stock opened at $233.62 on Wednesday. Astera Labs has a 1 year low of $97.89 and a 1 year high of $499.48. The business’s fifty day moving average is $306.13 and its 200-day moving average is $255.53. The stock has a market cap of $40.53 billion, a PE ratio of 115.65 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business had revenue of $584.90 million during the quarter, compared to analyst estimates of $550.78 million. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The company’s revenue was up 153.6% on a year-over-year basis. Equities research analysts predict that Astera Labs will post 2.71 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at $431,109,432.75. This represents a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is owned by insiders.

Institutional Trading of Astera Labs

A number of institutional investors have recently added to or reduced their stakes in the business. Greenleaf Trust lifted its stake in shares of Astera Labs by 1.8% in the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after purchasing an additional 36 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Astera Labs by 74.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after acquiring an additional 41 shares in the last quarter. Integrated Advisors Network LLC lifted its holdings in Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock worth $350,000 after purchasing an additional 45 shares during the last quarter. Interchange Capital Partners LLC lifted its holdings in Astera Labs by 4.4% in the 3rd quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock worth $423,000 after purchasing an additional 50 shares during the last quarter. Finally, Glenmede Trust Co. NA boosted its position in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after purchasing an additional 51 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported record Q3 revenue of $584.9 million, up 49% quarter over quarter and 154% year over year. Adjusted earnings of $1.32 per share beat the $1.19 consensus estimate, as did revenue versus expectations of $550.78 million. Astera Labs Reports Third Quarter 2026 Financial Results
• Positive Sentiment: Growth was led by the Scorpio fabric-switch family, now Astera Labs’ largest product line, with volume production of the Scorpio X-Series 320-lane switch. The company also expanded products for memory, optical and copper connectivity, and rack-scale AI systems—supporting its opportunity in AI infrastructure. Q3 2026 Earnings Call Highlights
• Positive Sentiment: Reports said the company’s forward guidance also topped estimates, adding to the earnings beat and potentially reinforcing expectations for continued demand. Astera Labs Q3 Results and Guidance
• Negative Sentiment: The results arrive after a sharp retreat: a recent report said ALAB had fallen about 54% from its year-to-date high and broken below key support. That weakness may keep volatility elevated and leave investors focused on whether earnings growth can restore confidence. Astera Labs Stock and Key Support

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.